Hybrid Nephrology Asset Lead: Strategy & Launch

Biogen; San Francisco (CA); Hybrid; USD 204,000 - 281,000; Full time

Benefits offered by this job

Bonus opportunities

Equity incentives

Health benefits

401(k) match

Tuition reimbursement

Paid time off

Job summary

Biogen seeks a CMC Asset Lead to drive development and launch of nephrology assets, including a Phase 3 program, with commercialization planned for 2028–2030. You will manage asset strategy, launch planning, lifecycle management, and project financials in a matrix, cross-functional environment.

This hybrid role can be based in RTP, NC; Cambridge, MA; or San Francisco, CA, requiring strategic thinking, collaboration, and ability to influence stakeholders to advance Biogen’s nephrology portfolio.

Qualifications

• Minimum of 12 years of experience with a focus on matrix management.
• Proven matrix leadership across program teams and full product life cycle including commercial launch.
• Experience in alliance management, preferably global, and understanding of business contracts.
• Expertise in CMC, supply chain, or life cycle management development from IND to NDA/BLA.
• Strong strategic, organizational and relationship development skills.
• Ability to lead and influence strategic direction with diverse teams.

Responsibilities

• Develop and maintain a 5-year PO&T Asset Strategy and an 18-month rolling Tactical Plan.
• Lead the cross-functional Asset Team to deliver on strategic objectives.
• Manage financial accountability, including AOP and FTE allocations, and monitor impacts on the P&L.
• Develop business cases for key initiatives and secure management endorsement.
• Proactively resolve conflicts related to Asset Strategy with governance boards.
• Serve as the PO&T representative on commercial or development teams, influencing decisions.
• Collaborate with PO&T and other stakeholders to align asset development with business objectives.
• Oversee asset planning and execution for late-stage activities and launch.
• Conduct asset scenario planning and evaluation for development, launch, and lifecycle management.

Skills

Matrix leadership

Strategic thinking

Stakeholder management

Communication

Negotiation

Decision making

Biopharma experience

Education

BS/BE in Sciences/Engineering

MS/PhD/MBA preferred

Tools

Contract management tools

Job description

Biogen seeks a CMC Asset Lead to drive development and launch of nephrology assets, including a Phase 3 program, with commercialization planned for 2028–2030. You will manage asset strategy, launch planning, lifecycle management, and project financials in a matrix, cross-functional environment.

This hybrid role can be based in RTP, NC; Cambridge, MA; or San Francisco, CA, requiring strategic thinking, collaboration, and ability to influence stakeholders to advance Biogen’s nephrology portfolio.